Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sims

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cell Reports|June 22, 2022
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastomaRajappa S Kenchappa, Athanassios Dovas, Michael G Argenziano, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination TherapyJeremy Worley, Heeju Noh, Daoqi You, et al.
Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.
JCO Oncology Advances|May 7, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage ActivationGulam A Manji, Liam J Stanton, Angela C Hirbe, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Cancer Cell|April 30, 2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsSilvia Affo, Ajay Nair, Francesco Brundu, et al.
Cancer Cell|June 15, 2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsSilvia Affo, Ajay Nair, Francesco Brundu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Paired Tumor Biopsies Reveal Spatiotemporal Myeloid Remodeling After Local Chemotherapy in GlioblastomaAnthony J Tang, Matthew R Warren, Peter J Chabot, et al.
Nature Cancer|February 12, 2022
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastomaVíctor A Arrieta, Andrew X Chen, J Robert Kane, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cell Reports|June 22, 2022
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastomaRajappa S Kenchappa, Athanassios Dovas, Michael G Argenziano, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination TherapyJeremy Worley, Heeju Noh, Daoqi You, et al.
Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.
JCO Oncology Advances|May 7, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage ActivationGulam A Manji, Liam J Stanton, Angela C Hirbe, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Cancer Cell|April 30, 2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsSilvia Affo, Ajay Nair, Francesco Brundu, et al.
Cancer Cell|June 15, 2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsSilvia Affo, Ajay Nair, Francesco Brundu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Paired Tumor Biopsies Reveal Spatiotemporal Myeloid Remodeling After Local Chemotherapy in GlioblastomaAnthony J Tang, Matthew R Warren, Peter J Chabot, et al.
Nature Cancer|February 12, 2022
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastomaVíctor A Arrieta, Andrew X Chen, J Robert Kane, et al.
Pageof 3